Logo Lucerna-Chem
+41 41 420 9636

Regulatory Status

Article Status


BC1618


Catalog Number Pack Size List Price* Promo Price* Quantity
HY-134656-5MG 5 mg 239,00 203,20 Add
HY-134656-10MMO 10 mM * 1 mL 263,00 223,60 Add
HY-134656-10MG 10 mg 418,00 355,30 Add
HY-134656-25MG 25 mg 775,00 658,80 Add
HY-134656-50MG 50 mg 1'045,00 888,30 Add
HY-134656-100MG 100 mg 1'485,00 1'262,30 Add

* CHF, excl. 7.7% VAT and shipping costs


Product Description

BC1618, an orally active Fbxo48 inhibitory compound, stimulates Ampk-dependent signaling (via preventing activated pAmpkα from Fbxo48-mediated degradation). BC1618 promotes mitochondrial fission, facilitates autophagy and improves hepatic insulin sensitivity.

Category Biochemicals
Supplier MedChem Express
Application Cancer-Kinase/protease
Regulatory Status RUO
Format Solubility: DMSO : 100 mg/mL (240.70 mM; Need ultrasonic) ; H2O : < 0.1 mg/mL (insoluble)
Grade Clinical information: No Development Reported
Purity 99.83%
Molecular Formula C24H24F3NO2
Molecular Weight 415.45
CAS-Number [2222094-18-8]
Storage Conditions Powder -20°C 3 years; In solvent -80°C 6 months, -20°C 1 month
Product Line Research
Tech. Data Sheet View datasheet
Link To Supplier http://www.medchemexpress.com
Material Safety Data Sheet Download PDF
Call us

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56
info@lucerna-chem.ch

Business Hours
From Monday through Friday
08:00 – 12:00
13:00 – 17:00

Ask us

Technical Support
tech@lucerna-chem.ch

Business Development
business.dev@lucerna-chem.ch

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern

Newsletter













If you have already subscribed to our newsletter and would like to update your details or cancel it, please click here.


© Copyright 2021 Lucerna-Chem AG, Switzerland